#rd
Biosimulation Market to Grow at 16%+ CAGR Reaching USD 11.3 Billion by 2031, Driven by Increasing Adoption in Drug Development and Regulatory Applications: Mordor Intelligence
The biosimulation market is driven by the rising complexity of drug development, increasing demand for cost-efficient R&D processes, and growing adoption of modeling and simulation tools. North America leads the market, while Asia-Pacific is emerging as a hig…
Sun Pharma’s deal to buy Merck-spinoff Organon ticks the right box on acquisition cost if not R&D
Sun Pharma’s acquisition of US-based Organon looks like a financial bargain for the global scale and market access it offers. But the Indian drugmaker may need to look elsewhere for an R&D boost that could put it at the cutting edge of healthcare.